RGBOQ — ReGen Biologics Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
C2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | 2008 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K/A | 10-K/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -7.2 | -11.7 | -12.7 | -10.4 | -9.95 |
Depreciation | |||||
Non-Cash Items | 0.662 | 0.603 | 1.22 | 1.46 | 2.15 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.374 | 1.36 | -0.865 | -0.332 | 0.921 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -6.11 | -9.72 | -12.2 | -9.16 | -6.78 |
Capital Expenditures | -0.019 | -0.125 | -0.182 | -0.171 | -0.029 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | -4 | 3.35 | 0.548 | 0.1 |
Change in Net Investments | |||||
Cash from Investing Activities | -0.019 | -4.12 | 3.17 | 0.377 | 0.071 |
Financing Cash Flow Items | — | — | — | 0 | -0.128 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 10 | 11.2 | 6.84 | 5.55 | 2.89 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 3.87 | -2.65 | -2.27 | -3.26 | -3.76 |